List of Kybella drug patents
Kybella is owned by Kythera Biopharms.
Kybella contains Deoxycholic Acid.
Kybella has a total of 15 drug patents out of which 0 drug patents have expired.
Kybella was authorised for market use on 29 April, 2015.
Kybella is available in solution;subcutaneous dosage forms.
Kybella can be used as improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults by means of reducing submental fat volume as described in the approved labeling, method for reduction of submental fat.
The generics of Kybella are possible to be released after 02 March, 2030.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8242294 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
May, 2028
(5 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8846066 | KYTHERA BIOPHARMS | Methods and related compositions for reduction of fat and skin tightening |
Feb, 2025
(2 years from now) | |
| US8298556 | KYTHERA BIOPHARMS | Methods and related compositions for the non-surgical removal of fat |
Aug, 2025
(2 years from now) | |
| US7622130 | KYTHERA BIOPHARMS | Methods and compositions for the non-surgical removal of fat |
Dec, 2027
(4 years from now) | |
| US7754230 | KYTHERA BIOPHARMS | Methods and related compositions for reduction of fat |
Dec, 2027
(4 years from now) | |
| US8546367 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US9949986 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US9636349 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US9522155 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US8461140 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US8883770 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(5 years from now) | |
| US8653058 | KYTHERA BIOPHARMS | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
Mar, 2030
(7 years from now) | |
| US8101593 | KYTHERA BIOPHARMS | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(7 years from now) | |
| US8367649 | KYTHERA BIOPHARMS | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(7 years from now) | |
| US10500214 | KYTHERA BIOPHARMS | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(7 years from now) | |
Drugs and Companies using DEOXYCHOLIC ACID ingredient
Market Authorisation Date: 29 April, 2015
Treatment: Method for reduction of submental fat; Improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults by means of reducing submental fat volume as described in the approved labeling
Dosage: SOLUTION;SUBCUTANEOUS
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic